Institutional Ownership Agios Pharmaceuticals, Inc. (AGIO)
This table provides information about the institutional ownership of Agios Pharmaceuticals, Inc. (AGIO). We have compiled data on the 232 institutions that hold shares in the stock, with a total of 58.1 Million shares, which have been reported (via 13F filing form) to have a value of $3.23 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Invesco Ltd.
Atlanta, GA |
Nov 12, 2024 Q3 2024 |
118,947
shares
|
$6.62 Million
0.0% of portfolio
|
Q3 2024
Added 0.79%
|
|
|
American Century Companies Inc
Kansas City, MO |
Nov 12, 2024 Q3 2024 |
114,220
shares
|
$6.36 Million
0.0% of portfolio
|
Q3 2024
Added 20.89%
|
|
|
Ubs Group Ag
|
Nov 14, 2024 Q3 2024 |
114,186
shares
|
$6.36 Million
0.0% of portfolio
|
Q3 2024
Added 64.63%
|
|
|
Ubs Asset Management Americas Inc
Chicago, IL |
Nov 14, 2024 Q3 2024 |
113,229
shares
|
$6.3 Million
0.0% of portfolio
|
Q3 2024
Reduced 9.76%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
111,632
shares
|
$6.22 Million
0.0% of portfolio
|
Q1 2024
Added 2.23%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 13, 2024 Q3 2024 |
110,923
shares
|
$6.18 Million
0.0% of portfolio
|
Q3 2024
Reduced 14.94%
|
|
|
Allianz Asset Management Gmb H
Munich, 2M |
Nov 12, 2024 Q3 2024 |
109,058
shares
|
$6.07 Million
0.01% of portfolio
|
Q3 2024
Reduced 2.24%
|
|
|
Summit Partners Public Asset Management, LLC
Boston, MA |
Nov 14, 2024 Q3 2024 |
101,730
shares
|
$5.66 Million
0.16% of portfolio
|
Q3 2024
New holding
|
|
|
Moore Capital Management, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
100,000
shares
|
$5.57 Million
0.09% of portfolio
|
Q3 2024
Added 66.67%
|
|
|
Swiss National Bank
Zurich, V8 |
Nov 07, 2024 Q3 2024 |
99,760
shares
|
$5.55 Million
0.0% of portfolio
|
Q3 2024
Added 0.3%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
94,223
shares
|
$5.25 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.88%
|
|
|
Rafferty Asset Management, LLC
New York, NY |
Nov 13, 2024 Q3 2024 |
89,498
shares
|
$4.98 Million
0.01% of portfolio
|
Q3 2024
Added 16.45%
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2024 Q3 2024 |
84,417
shares
|
$4.7 Million
0.01% of portfolio
|
Q3 2024
Added 239.98%
|
|
|
Silvercrest Asset Management Group LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
79,885
shares
|
$4.45 Million
0.02% of portfolio
|
Q3 2024
New holding
|
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Nov 14, 2024 Q3 2024 |
77,930
shares
|
$4.34 Million
0.0% of portfolio
|
Q3 2024
Added 150.68%
|
|
|
Eam Investors, LLC
Solana Beach, CA |
Nov 13, 2024 Q3 2024 |
74,273
shares
|
$4.14 Million
0.57% of portfolio
|
Q3 2024
Added 0.18%
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2024 Q3 2024 |
73,402
shares
|
$4.09 Million
0.0% of portfolio
|
Q3 2024
Added 2.1%
|
|
|
Legal & General Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
73,101
shares
|
$4.07 Million
0.0% of portfolio
|
Q3 2024
Added 20.38%
|
|
|
Citigroup Inc
|
Nov 12, 2024 Q3 2024 |
72,064
shares
|
$4.01 Million
0.0% of portfolio
|
Q3 2024
Added 196.35%
|
|
|
Eaton Vance Management
Boston, MA |
Nov 14, 2022 Q3 2022 |
68,447
shares
|
$3.81 Million
0.0% of portfolio
|
Q3 2022
Reduced 8.7%
|
|
|
Panagora Asset Management Inc
Boston, MA |
Nov 13, 2024 Q3 2024 |
67,985
shares
|
$3.79 Million
0.01% of portfolio
|
Q3 2024
Reduced 61.12%
|
|
|
Sector Gamma As
|
Nov 13, 2024 Q3 2024 |
67,908
shares
|
$3.78 Million
0.98% of portfolio
|
Q3 2024
Reduced 44.27%
|
|
|
Exome Asset Management LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
66,200
shares
|
$3.69 Million
2.02% of portfolio
|
Q3 2024
New holding
|
|
|
Voya Investment Management LLC
Atlanta, GA |
Nov 14, 2024 Q3 2024 |
63,740
shares
|
$3.55 Million
0.0% of portfolio
|
Q3 2024
Added 78.87%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
60,792
shares
|
$3.38 Million
0.0% of portfolio
|
Q3 2024
Reduced 6.65%
|